Stocks · News reference

bioAffinity Technologies shares are trading higher after the company announced it is presenting two posters highlighting CyPath Lung at the 2026 NAVREF Annual Conference.

Sep 22, 2026, 2:50 PMBenzinga Newsdesk

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Sep 22, 2026, 2:50 PM
Checked: Sep 22, 2026, 2:50 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaSep 22, 2026, 12:03 PMBenzinga Newsdesk
bioAffinity Technologies To Present Clinical And Veteran-Focused Data On CyPath Lung At NAVREF 2026 Annual Conference
Presentations demonstrate beneficial role for CyPath Lung in veteran lung cancer careNAVREF 2026 focuses on innovative research to improve healthcare for veteran
BIAF
BenzingaSep 17, 2026, 7:13 PMHenry Khederian
BioAffinity Technologies Stock Surges Following Hong Kong Patent Grant
Shares of BioAffinity Technologies are surging Thursday after securing a key Hong Kong patent for its CyPath Lung diagnostic.
BIAF BIAFW
BenzingaSep 17, 2026, 3:08 PMBenzinga Newsdesk
bioAffinity Technologies shares are trading higher after the company announced that the Hong Kong Intellectual Property Department has granted a patent for the proprietary platform technology for predicting the likelihood of lung cancer using flow cytometry and fluorescent markers to characterize cell populations in sputum.
BIAF